Large-scale testing (Phase 3)Study completedNCT03123939What this trial is testingPhase III B in Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia Novartis Pharmaceuticals 69
Testing effectiveness (Phase 2)Study completedNCT00388193What this trial is testingRituximab Combined With Chemotherapy in Burkitt's LymphomaWho this might be right forAcute Lymphoblastic LeukemiaBurkitt's Lymphoma PETHEMA Foundation 20
Testing effectiveness (Phase 2)Study completedNCT00036738What this trial is testingFludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or NilotinibWho this might be right forAdult Acute Lymphoblastic Leukemia in RemissionAdult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1Blastic Phase+7 more Fred Hutchinson Cancer Center 28
Large-scale testing (Phase 3)Study completedNCT00002456What this trial is testingGraft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow TransplantationWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00046683What this trial is testingEfficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic LeukemiaWho this might be right forB Cell Chronic Lymphocytic Leukemia Genzyme, a Sanofi Company 284
Early research (Phase 1)Study completedNCT00006042What this trial is testingCyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableStudy completedNCT00956475What this trial is testingQuality of Life in Younger Leukemia and Lymphoma SurvivorsWho this might be right forAnxiety DisorderCancer SurvivorFatigue+7 more Case Comprehensive Cancer Center 48
Early research (Phase 1)Study completedNCT01129193What this trial is testingAR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+64 more Amir Mortazavi 44
Large-scale testing (Phase 3)Study completedNCT00666211What this trial is testingOpioid Titration Order Sheet or Standard Care in Treating Patients With Cancer PainWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more Vanderbilt-Ingram Cancer Center 98
Not applicableEnded earlyNCT00726830What this trial is testingMethadone, Morphine, or Oxycodone in Treating Pain in Patients With CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00611351What this trial is testingBusulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+4 more University of Nebraska 5
Testing effectiveness (Phase 2)UnknownNCT01279707What this trial is testingMonoclonal Antibodies in Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (MARALL)Who this might be right forRecurrent or Refractory B Cell Acute Lymphoblastic Leukaemia Queen Mary University of London 55
Testing effectiveness (Phase 2)Study completedNCT00082888What this trial is testingTipifarnib in Treating Patients With Relapsed or Refractory LymphomaWho this might be right forAnaplastic Large Cell LymphomaExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueMature T-Cell and NK-Cell Non-Hodgkin Lymphoma+10 more National Cancer Institute (NCI) 93
Early research (Phase 1)Active Not RecruitingNCT01860937What this trial is testingT-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic LeukemiaWho this might be right forRelapsed B-Cell Acute Lymphoblastic Leukemia Memorial Sloan Kettering Cancer Center 23
Testing effectiveness (Phase 2)Ended earlyNCT01419795What this trial is testingLenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell TransplantWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more Fred Hutchinson Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00004157What this trial is testingInterleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid TumorsWho this might be right forBreast CancerGestational Trophoblastic TumorKidney Cancer+5 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06395103What this trial is testingSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)Who this might be right forB-cell Acute Lymphoblastic LeukemiaDiffuse Large B-cell LymphomaBurkitt Lymphoma+2 more Merck Sharp & Dohme LLC 90
Testing effectiveness (Phase 2)Looking for participantsNCT05255601What this trial is testingEvaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin LymphomaWho this might be right forLymphoma, Non-HodgkinHodgkin Disease Bristol-Myers Squibb 68
Testing effectiveness (Phase 2)WithdrawnNCT01652014What this trial is testingSingle or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Study completedNCT06705530What this trial is testingEvaluate the Tolerability, Safety, and Efficacy of an Anti-CD19 CAR-T Product in Patients With B-cell Lymphoproliferative DisordersWho this might be right forNon-Hodgkin Lymphoma, B-cellAcute Lymphoblastic Leukemia ALL National Research Center for Hematology, Russia 58